Dyne Therapeutics Inc (NAS:DYN)
$ 31.13 1.9 (6.5%) Market Cap: 3.17 Bil Enterprise Value: 2.28 Bil PE Ratio: 0 PB Ratio: 4.49 GF Score: 42/100

Dyne Therapeutics Inc at Stifel CNS Days (Virtual) Transcript

Mar 28, 2022 / 05:00PM GMT
Release Date Price: $9 (+5.76%)
Paul Matteis
Stifel Financial Corp. - Analyst

Thank you very much, everybody, for continuing on. It's my pleasure, as always, to be hosting the Dyne executive management team, focused on neuromuscular diseases. And looking forward to a great conversation.

Maybe we can start, Josh, by having you give a quick overview and update on the lead programs and then we can get into more specifics. Is that cool?

Josh Brumm
Dyne Therapeutics, Inc. - President & CEO

Yeah, happy to do it. And Paul, thanks again to you and Stifel for having us today. We are really excited to be here. Just to remind everyone before we start that we will be making forward-looking statements. So as always, please refer to our SEC filings for more information.

So as always, it's exciting times for us here at Dyne. As you know, it's just over three years we've moved from concepts, preparing down to the clinic and multiple programs. We've been driven by our commitment to patients, our urgency to deliver the new hope for patients. And that will continue to guide our work

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot